Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

NCT02357420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

393

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetes Mellitus Complications
Gastroparesis

Interventions

DRUG: Relamorelin
DRUG: Placebo

Sponsor

Allergan